These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27984520)

  • 21. Technical, Immunological, and Ethical Similarities and Differences Between Vascularized Composite Allotransplantation and Solid Organ Transplantation in Current Practice.
    Ozkan O; Ertosun MG; Ozkan O
    Transplant Proc; 2018 Dec; 50(10):3775-3782. PubMed ID: 30577269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Considerations for Vascularized Composite Allotransplantation of the Eye.
    Davidson EH; Wang EW; Yu JY; Fernandez-Miranda JC; Wang DJ; Li Y; Miller M; Sivak WN; Bourne D; Wang H; Solari MG; Schuman JS; Washington KM
    J Craniofac Surg; 2016 Oct; 27(7):1622-1628. PubMed ID: 27513765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investing in neurosurgery innovations: an editorial.
    Krishna C; Natarajan SK; Hopkins LN
    Neurosurgery; 2014 Aug; 61 Suppl 1():135-6. PubMed ID: 25032542
    [No Abstract]   [Full Text] [Related]  

  • 25. Is Vascularized Composite Allograft Transplantation Experimental or an Accepted Surgical Procedure: Results from a National Survey.
    Colakoglu S; Tebockhorst S; Mathes DW
    J Reconstr Microsurg; 2020 May; 36(4):276-280. PubMed ID: 31986534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innovation-Based Practice (IBP) Versus Evidence-Based Practice (EBP): A New Perspective That Assesses and Differentiates Evidence and Innovation.
    Ackerman MH; Porter-O'Grady T; Malloch K; Melnyk BM
    Worldviews Evid Based Nurs; 2018 Jun; 15(3):159-160. PubMed ID: 29729656
    [No Abstract]   [Full Text] [Related]  

  • 27. Unproven Stem Cell Treatments for Lung Disease-An Emerging Public Health Problem.
    Ikonomou L; Panoskaltsis-Mortari A; Wagner DE; Freishtat RJ; Weiss DJ;
    Am J Respir Crit Care Med; 2017 Apr; 195(7):P13-P14. PubMed ID: 28362195
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulatory oversight in the United States of vascularized composite allografts.
    Glazier AK
    Transpl Int; 2016 Jun; 29(6):682-5. PubMed ID: 26284312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technology and innovation in arthroscopic and related surgery.
    Lubowitz JH; Poehling GG
    Arthroscopy; 2011 Jan; 27(1):2-4. PubMed ID: 21187245
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of complementary therapies into NHS trust and private hospital practice.
    Graham L; Goldstone L; Ejindu A; Baker J; Asiedu-Addo E
    Complement Ther Nurs Midwifery; 1998 Dec; 4(6):160-5. PubMed ID: 10205411
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal allotransplantation in retroperitoneal fibrosis: technical aspects.
    Arudchelvam J; Zafras MZM; Rajiev BJ; Nazar L
    Ceylon Med J; 2018 Jun; 63(2):86-87. PubMed ID: 30064187
    [No Abstract]   [Full Text] [Related]  

  • 33. Hand allotransplantation: operating room set-up and team coordination.
    Pulos N; Shaked A; Abt PL; Doll SL; McAndrew CT; Chang B; Levin LS
    Tech Hand Up Extrem Surg; 2015 Jun; 19(2):68-72. PubMed ID: 25989395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation by Mesenchymal Stem Cells: Lessons From Vascularized Composite Allotransplantation.
    Hoogduijn MJ
    Transplantation; 2017 Jan; 101(1):30-31. PubMed ID: 27741042
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical innovation.
    Dejong CH; Earnshaw JJ
    Br J Surg; 2015 Jan; 102(2):e8-9. PubMed ID: 25627138
    [No Abstract]   [Full Text] [Related]  

  • 37. Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation.
    Klein HJ; Schanz U; Hivelin M; Waldner M; Koljonen V; Guggenheim M; Giovanoli P; Gorantla VS; Fehr T; Plock JA
    Burns; 2016 Mar; 42(2):246-57. PubMed ID: 26392022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rare diseases: Innovation laboratories for human health].
    Braun S
    Presse Med; 2012 May; 41 Suppl 1():S48-50. PubMed ID: 22464890
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel clinical trial designs for innovative therapies.
    Schellens JH; Beijnen JH
    Clin Pharmacol Ther; 2009 Feb; 85(2):212-6. PubMed ID: 19109591
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.